Raleigh drug firm’s pill treatment shows promise in reducing COVID-19 mortality
RedHill Biopharma is reporting a 62% reduction in mortality for severe COVID-19 patients using its investigational oral pill-based therapy, opaganib.
Read More
RedHill Biopharma
Tech Today: TransEnterix raises $31M; RedHill secures $25M; Women in Climate Tech launches; cannabinoid therapeutics; Parexel inclusion
TransEnterix and RedHill BioPharma are raising cash; a Roxoboro startup is pursuing cannabinoid therapeutics; a new group – Women in Climate Tech – launches in Durham, and Parexel is expanding inclusion efforts for clinical trials.
Read More
Red Hill Biopharma, which has an HQ in Raleigh, to expand production capability
RedHill Biopharma, which maintains its US headquarters in Raleigh, says it is beefing up its manufacturing capabilities in deals with two US manufacturers.
Read More
Potential COVID-19 treatment has ‘clear and compelling’ effect, says biopharma with US HQ in Raleigh
RedHill Biopharma, an Israeli company with U.S. headquarters in Raleigh, says one of its drug candidates, opaganib, completely inhibited the replication of the coronavirus that causes COVID-19 in a laboratory study.
Read More
RedHill Biopharma reports positive results with drug targeting COVID-19
RedHill Biopharma is reporting positive early results from one of its potential treatments for COVID-19. Here are the details.
Read More
Raleigh’s RedHill Biopharma approved for US COVID-19 study
The Israeli specialty biopharmaceutical company, which has its U.S. commercial headquarters in Raleigh, will conduct a Phase 2a clinical study of opaganib.
Read More
Drug shows promise against COVID-19, says RedHill, which has US HQ in Raleigh
RedHill Biopharma, an Israeli specialty company with U.S. commercial headquarters in Raleigh, reports that all six COVID-19 patients who recently received its investigative drug, opaganib, got better.
Read More
RedHill Biopharma, which has US HQ in Raleigh, pursues second COVID-19 treatment
RedHill Biopharma is another step closer to getting one of its potential treatments for COVID-19 tested.
Read More
Tech today: Serga in-building wireless; Bandwidth, T-Mobile update; Kymera closes acquisition + DisposeRX, Open Invention Network, RedHill news
The coronavirus hasn’t brought all business to a halt. Headlines today include news from Charlotte-based Serga, Bandwidth.com, materials firm Kymera, RedHill BioPharma, the Open Invention Network and a reminder to clean out your medicine cabinet from Dispose RX.
Read More- 1
- 2
